Rickets: Clinical Trials

17 trials for Rickets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 3 unknown, 1 active not recruiting, 1 recruiting. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Completed 11, Unknown 3, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Rickets: new trials by email Literature Review of Rickets trials Research Report on Rickets

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
palicalcitol - Chronic Kidney Disease-Mineral and Bone Disorder
Phase 4UnknownXiaoyan Jia802023-04-012024-03-08
PRevEnting FracturEs in REnal Disease - 1
Denosumab 60 mg/ml, Calcium and vitamin D prophylaxis, Monitoring of post-injection calcium and phosphate - Kidney Diseases, Dialysis; Complications
Phase 4Active not recruitingWestern University, Canada602022-06-112025-05-31
Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
Vitamin D, Placebo Oral Tablet - Restless Leg Disorder, Renal Disease Bone
Phase 4WithdrawnUniversity of Sao Paulo General Hospital2022-03-312021-09-30
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy - Adynamic Bone Disease, Chronic Kidney Diseases
Phase 4RecruitingDitte Hansen482021-12-152024-04-23
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH
KRN23 - X-linked Hypophosphatemia (XLH)
Phase 4CompletedKyowa Kirin Co., Ltd.282021-11-012024-07-09
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH
KRN23 - X-linked Hypophosphatemia (XLH)
Phase 4CompletedKyowa Kirin Co., Ltd.182021-09-282024-07-09
Examining the Effect of Burosumab on Muscle Function
Burosumab Injection [Crysvita] - X-linked Hypophosphatemia
Phase 4CompletedYale University102019-11-132023-08-24
Burosumab in Children and Adolescents With X-linked Hypophosphatemia
Burosumab Injection - Rare Diseases, X-linked Hypophosphatemia
Phase 4UnknownBicetre Hospital572018-03-182020-06-05
Different Effects of Non-calcium Phosphate Binders on Serum Calcium
Sevelamer Hydrochloride, Lanthanum Carbonate - Chronic Kidney Disease
Phase 4CompletedMedical University of Lodz342018-03-012021-07-27
Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Cinacalcet HCl - Hyperparathyroidism; Secondary, Renal
Phase 4CompletedKyowa Kirin China Pharmaceutical Co., Ltd.7502017-04-192024-04-29
Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
Calcitriol - X-linked Hypophosphatemia
Phase 4UnknownPeking Union Medical College Hospital1002017-01-012019-01-30
Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan
Asfotase Alfa - Hypophosphatasia
Phase 4CompletedAlexion Pharmaceuticals, Inc.132015-06-012017-05-08
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
Zoledronic acid - Renal Osteodystrophy
Phase 4CompletedUniversity of Sao Paulo General Hospital342012-07-012014-05-19
Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
Vitamin D2, 1,25(OH)2 Vit D3 - Vitamin D Deficiency
Phase 4CompletedDongliang Zhang, MD2042012-07-012016-02-15
Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density
25 OH vitamin D - Vitamin D Deficiency, Secondary Hyperparathyroidism
Phase 4CompletedClalit Health Services2102010-01-012014-07-21
Vitamin D and Genetics in Nutritional Rickets
Vitamin D + Calcium, Calcium, Vitamin D2 - Nutritional Rickets
Phase 4CompletedMayo Clinic1092004-01-012012-07-04
Osteopenia and Renal Osteodystrophy: Evaluation and Management
pamidronate - Osteopenia, Renal Osteodystrophy
Phase 4CompletedUS Department of Veterans Affairs2002-10-012009-01-21

Narrower conditions

Chronic Kidney Disease-Mineral and Bone Disorder (9)  ·  Familial Hypophosphatemic Rickets (5)  ·  Vitamin D Deficiency (4)  ·  Hyperparathyroidism, Secondary (3)  ·  Bone Diseases (2)  ·  Hyperparathyroidism (2)  ·  Osteomalacia (2)  ·  Renal Insufficiency, Chronic (2)  ·  Bone Diseases, Metabolic (1)  ·  Fractures, Bone (1)  ·  Heart Diseases (1)  ·  Hypophosphatasia (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)

Broader conditions

Avitaminosis (17)  ·  Calcium Metabolism Disorders (17)  ·  Deficiency Diseases (17)  ·  Malnutrition (17)  ·  Metabolic Diseases (17)  ·  Musculoskeletal Diseases (17)  ·  Nutrition Disorders (17)  ·  Nutritional and Metabolic Diseases (17)  ·  Bone Diseases, Metabolic (16)  ·  Bone Diseases (15)  ·  Female Urogenital Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (14)  ·  Male Urogenital Diseases (14)  ·  Urogenital Diseases (14)

Interventions

burosumab (4)  ·  Calcitriol (3)  ·  Calcium (2)  ·  Ergocalciferols (2)  ·  Vitamin D (2)  ·  Blood Specimen Collection (1)  ·  Calcium Carbonate (1)  ·  Cholecalciferol (1)  ·  Cinacalcet (1)  ·  Denosumab (1)  ·  Heart Function Tests (1)  ·  Pamidronate (1)  ·  Restraint, Physical (1)  ·  Sevelamer (1)  ·  Teriparatide (1)

Sponsors

Kyowa Kirin Co., Ltd. (2)  ·  University of Sao Paulo General Hospital (2)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Bicetre Hospital (1)  ·  Clalit Health Services (1)  ·  Ditte Hansen (1)  ·  Dongliang Zhang, MD (1)  ·  Kyowa Kirin China Pharmaceutical Co., Ltd. (1)  ·  Mayo Clinic (1)  ·  Medical University of Lodz (1)  ·  Peking Union Medical College Hospital (1)  ·  US Department of Veterans Affairs (1)  ·  Western University, Canada (1)  ·  Xiaoyan Jia (1)  ·  Yale University (1)

Countries

China (6)  ·  Brazil (2)  ·  United States (2)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Israel (1)  ·  Nigeria (1)  ·  Poland (1)

Top investigators

Aihua Zhang (1)  ·  Aili Jiang (1)  ·  Anat Tsur, MD (1)  ·  Chaosheng Chen (1)  ·  Ditte Hansen, MD, PhD (1)  ·  Dongliang Zhang, Doctor (1)  ·  Elias David-Neto, MD (1)  ·  Guanqing Xiao (1)  ·  Guohua Ding (1)  ·  Hong Liu (1)  ·  Jianming Ye (1)  ·  Jianying Niu (1)  ·  Jiazhuang Lou (1)  ·  Jing Chen (1)  ·  Junwei Yang (1)

Results publications

PMID 24748637, PMID 33305842, PMID 34754193, PMID 40935429

NIH funding

2018 (1)